Skandinaviska Enskilda Banken (SEB)’s Collegium Pharmaceutical COLL Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-33,300	Closed	-$789K	–	1058
2021 Q1	$789K	Hold	33,300	–	–	0.01%	871
2020 Q4	$667K	Sell	33,300 -41,400	-55%	-$808K	﹤0.01%	872
2020 Q3	$1.55M	Sell	74,700 -8,300	-10%	-$150K	0.01%	643
2020 Q2	$1.45M	Buy	83,000 +6,200	+8%	+$121K	0.01%	645
2020 Q1	$1.25M	Buy	+76,800	New	+$1.59M	0.01%	605
2019 Q3	–	Sell	-14,900	Closed	-$196K	–	920
2019 Q2	$196K	Buy	+14,900	New	+$199K	﹤0.01%	776

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s COLL Position: Q2 2021 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Collegium Pharmaceutical (COLL) in Q2 2021, closing a stake of 33,300 shares — an estimated $789K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in COLL in Q2 2019 and held it in 6 quarters. The position peaked at $1.55M in Q3 2020. 158 funds tracked by Wall St. Rank hold COLL as of Q2 2021.

Skandinaviska Enskilda Banken (SEB) reported no remaining Collegium Pharmaceutical position as of Q2 2021 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 33,300 Collegium Pharmaceutical shares in Q2 2021, an estimated $789K.
Skandinaviska Enskilda Banken (SEB) first reported a position in Collegium Pharmaceutical in Q2 2019 and held it in 6 quarters.
Skandinaviska Enskilda Banken (SEB)'s Collegium Pharmaceutical position peaked at $1.55M in Q3 2020.
158 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2021.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2021, filed 10 Aug 2021.